Next-generation medium delivers up to 61% higher titers 1, faster workflows, and greater flexibility for insulin-dependent CHO cell lines WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc., unveiled the Gibco™ Efficient-Pro™ Medium (+) Insulin, a next-generation medium designed to increase titers to maximize productivity and elevate the performance of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results